EDGAR Filing Documents for 0001176256-15-000245

Form F-3 - Registration statement by foreign private issuers:

SEC Accession No. 0001176256-15-000245

Filing Date

2015-07-14

Accepted

2015-07-14 17:03:04

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	REGISTRATION STATEMENT	nymoxf3.htm	F-3	349243
2	OPINION OF ZOUVAS & ASSOCIATES LLP	exhibit5-1.htm	EX-5.1	17285
3	CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM	exhibit23-1.htm	EX-23.1	5088
4		exhibit5-1x1x1.jpg	GRAPHIC	13669
5		exhibit23-1x1x1.jpg	GRAPHIC	6366
6		image_001.jpg	GRAPHIC	4854
	Complete submission text file	0001176256-15-000245.txt		407296

Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2

Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2 1-800-936-9669

NYMOX PHARMACEUTICAL CORP (Filer) CIK: 0001018735 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-205659 | Film No.: 15987799
SIC: 2835 In Vitro & In Vivo Diagnostic Substances